The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes

SARICI, AHMET; AR, Muhlis; Yokus, Osman; ONGOREN, Seniz; Ayer, Mesut; Altindal, Sermin; Koker, Hilal; Kuzu, Omer

doi:10.1016/j.transci.2020.102845

The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes

Atıf İçin Kopyala

SARICI A. , AR M. C. , Yokus O., ONGOREN S., Ayer M., Altindal S., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.59, 2020 (SCI İndekslerine Giren Dergi)

Cilt numarası: 59 Konu: 5
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.transci.2020.102845
Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE

Özet

Purpose: Early comorbidity detection has been reported to be associated with treatment-related outcomes in several diseases. Two main goals of the present study were to investigate both the impact of comorbidities and transfusion frequencies on the survival and quality of life of patients with myelodysplastic syndromes (MDS).